Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Grüllich, C.; Powles, T.; Motzer, R. J.; George, D. J.; Jonasch, E.; Pal, S. K.; Tannir, N. M.; Signoretti, S.; Mai, T. H.; Scheffold, C.; Wang, E.; Aftab, D. T.; Escudier, B. J.; Choueiri, T. K. |
| Abstract Title: | Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (RCC) |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 41 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2018 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2018-09-01 |
| Start Page: | 201 |
| Language: | English |
| ACCESSION: | WOS:000446816500488 |
| PROVIDER: | wos |
| PUBMED: | 30261496 |
| DOI: | 10.1159/000492737 |
| Notes: | Meeting Abstract: P601 -- Source: Wos |
